SEC Form 4 · accession 0001628280-26-058874
Cellebrite DI Ltd. · CLBT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Nicholas Gee
Officer — Chief Marketing Officer
Period of report
Aug 24, 2026
Accepted (ET)
Aug 25, 2026 · 4:09 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001854587
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary shares, par value NIS 0.00001F2 | Aug 24, 2026 | S | 4,323 | $11.3605 | D | 135,281 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.06 to $11.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.